Organization Overview
Alternative names
azacitidine (vidaza) (1 trial)
bendamustine (treanda) (6 trials)
atezolizumab (Tecentriq) (2 trials)
axicabtagene ciloleucel (Yescarta) (1 trial)
bleomycin (blenoxane) (2 trials)
brentuximab vedotin (adcetris) (5 trials)
carboplatin (paraplatin) (1 trial)
etoposide (vepesid) (4 trials)
fludarabine (fludara) (1 trial)
glofitamab (Columvi) (1 trial)
ibrutinib (imbruvica) (3 trials)
Aggression (Phase 2)
Disease (Phase 2)
Hodgkin Disease (Phase 2)
Immunoblastic Lymphadenopathy (Phase 3)
Intraocular Lymphoma (Phase 2)
Leukemia (Phase 2)
Leukemia, Lymphocytic, Chronic, B-Cell (Phase 2)
Leukemia, Lymphoid (Phase 2)
Lymphoma (Phase 3)
Lymphoma, B-Cell (Phase 3)
Lymphoma, B-Cell, Marginal Zone (Phase 2)
Lymphoma, Follicular (Phase 3)
Lymphoma, Large B-Cell, Diffuse (Phase 3)
Lymphoma, Mantle-Cell (Phase 3)
Lymphoma, Non-Hodgkin (Phase 2)
Lymphoma, T-Cell (Phase 3)
Lymphoma, T-Cell, Peripheral (Phase 3)
Neoplasms (Phase 1)